| 0.996 | 0 | 0.996 | Antibacterial | | |
| 0.862 | 0 | 0.862 | Cell wall synthesis inhibitor | | |
| 0.447 | 0.092 | 0.447 | Apoptosis agonist | | |
| 0.326 | 0.057 | 0.326 | Interleukin 2 agonist | | |
| 0.302 | 0.049 | 0.302 | Angiogenesis stimulant | | |
| 0.323 | 0.072 | 0.323 | Immunostimulant | | |
| 0.269 | 0.039 | 0.269 | Peptidyltransferase inhibitor | | |
| 0.328 | 0.099 | 0.328 | Immunosuppressant | | |
| 0.187 | 0.039 | 0.187 | Bone formation stimulant | | |
| 0.166 | 0.027 | 0.166 | Antineoplastic antibiotic | | |
| 0.151 | 0.033 | 0.151 | Nav1.4 sodium channel blocker | | |
| 0.135 | 0.018 | 0.135 | Somatostatin 1 agonist | | |
| 0.236 | 0.125 | 0.236 | Caspase 3 stimulant | | |
| 0.11 | 0.024 | 0.11 | Selectin antagonist | | |
| 0.09 | 0.016 | 0.09 | Endothelin-converting enzyme inhibitor | | |
| 0.164 | 0.095 | 0.164 | Hepatoprotectant | | |
| 0.065 | 0.007 | 0.065 | Antibiotic Aminoglycoside-like | | |
| 0.182 | 0.13 | 0.182 | Antioxidant | | |
| 0.113 | 0.061 | 0.113 | Chelator | | |
| 0.054 | 0.007 | 0.054 | Protein 30S ribosomal subunit inhibitor | | |
| 0.211 | 0.165 | 0.211 | Apoptosis antagonist | | |
| 0.139 | 0.106 | 0.139 | Nitric oxide antagonist | | |
| 0.182 | 0.15 | 0.182 | DNA synthesis inhibitor | | |
| 0.059 | 0.032 | 0.059 | Protein 50S ribosomal subunit inhibitor | | |
| 0.106 | 0.08 | 0.106 | Topoisomerase II inhibitor | | |
| 0.034 | 0.018 | 0.034 | AMPA 2 receptor antagonist | | |
| 0.03 | 0.016 | 0.03 | 1,3-Beta-glucan synthase inhibitor | | |
| 0.019 | 0.01 | 0.019 | Angiotensin-converting enzyme 2 inhibitor | | |
| 0.08 | 0.071 | 0.08 | Transcription factor NF kappa B stimulant | | |
| 0.034 | 0.026 | 0.034 | Growth factor receptor-bound protein 2 antagonist | | |
| 0.05 | 0.046 | 0.05 | Angiotensin-converting enzyme inhibitor | | |
| 0.066 | 0.065 | 0.066 | Topoisomerase II alpha inhibitor | | |
| 0.033 | 0.032 | 0.033 | Somatostatin 1 antagonist | | |